<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT2017091435741N2</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2017-09-25</date_registration>
      <primary_sponsor>Vice chancellor of research and technology of shahroud university of medical science</primary_sponsor>
      <public_title>The  Effect  Of  Extended- PLISSIT Counseling Model On Function &amp; Sexual &amp; Marital intimacySatisfaction  Of  Post Myocardial  Infarction(MI) Patients</public_title>
      <acronym></acronym>
      <scientific_title>The  Effect  Of  Extended- PLISSIT Counseling Model On Function &amp; Sexual &amp; Marital intimacySatisfaction  Of  Post Myocardial Infarction(MI)Patients</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2017-09-11</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>90</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/26924</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Single blinded, Placebo: Not used, Assignment: Single, Purpose: Supportive.</study_design>
      <phase>N/A</phase>
      <hc_freetext>counseling effect on sexual satisfaction.</hc_freetext>
      <i_freetext>The intervention involves extended counseling. The PLISSIT Consulting Advisory model is broader than the new PLISSIT consulting model and is a PLISSIT developed model developed by Davis and Taylor in 2006 based on the same key concepts and four levels. With the difference that counseling and intervention in this model, unlike the PLISSIT model, which the therapist can go from one stage to the next, is not linear and cyclical.&#13;
The dual features of this model are as follows:&#13;
1. Allow explicitly at all stages and not just in the first step&#13;
2. Need to review and review interventions with patients&#13;
-3 Challenging your assumptions about the patient's position.&#13;
Steps include:&#13;
Let:P&#13;
Limited Information Step:LI&#13;
Specific Suggestions: SS&#13;
Intensive Therapy and referral:IT&#13;
Reflection and Review: The reflection and review of the elements added to the EX-PLISSIT model is one of the means of distinguishing this model with the PLISSIT model. In the EX-PLISSIT model, consideration and reflection of all interactions and interventions with the patient is necessary. By reflecting each intervention, the therapists will examine their actions and, by reviewing these interventions with patients, will be given the opportunity to give and receive more patients. The purpose of adding review and reflection to this model is to increase the therapist's self-awareness, so that the therapist and the client will select and implement the best treatment for the sex problem.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan></results_IPD_plan>
      <results_IPD_description></results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Somayeh Rezaie</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Shahroud University of Medical Sciences and Health Services, 7 Tir Square, Shahroud, Iran.</address>
        <city>Shahroud</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>3614773955</zip>
        <telephone>+98 23 3239 5054</telephone>
        <email>aram_ir2007@yahoo.com</email>
        <affiliation>Shahroud  university  of medical science</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>mahbobeh poorheydari</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Address: Shahroud University of Medical Sciences and Health Services, 7 Tir Square, Shahroud, Iran.</address>
        <city>Shahroud</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>3614773955</zip>
        <telephone>+98 23 3239 5054</telephone>
        <email>s.rezaie@shmu.ac.ir</email>
        <affiliation>shahroud medical university of science</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Inclusion criteria include: willingness to participate in the study, ages 30-65, married, sexually active, being at lower risk for the International Association for Cardiac Association with less than three risk factors Cardiovascular (except age), controlled blood pressure. Exit criteria include: patient dissatisfaction, chest pain, uncontrolled blood pressure, history of heart attacks, moderate to severe illness.</inclusion_criteria>
      <agemin>30 years</agemin>
      <agemax>65 years</agemax>
      <gender>Both</gender>
      <exclusion_criteria></exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code></hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword></hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Behavior</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>The intervention involves extended counseling. The PLISSIT Consulting Advisory model is broader than the new PLISSIT consulting model and is a PLISSIT developed model developed by Davis and Taylor in 2006 based on the same key concepts and four levels. With the difference that counseling and intervention in this model, unlike the PLISSIT model, which the therapist can go from one stage to the next, is not linear and cyclical.&#13;
The dual features of this model are as follows:&#13;
1. Allow explicitly at all stages and not just in the first step&#13;
2. Need to review and review interventions with patients&#13;
-3 Challenging your assumptions about the patient's position.&#13;
Steps include:&#13;
Let:P&#13;
Limited Information Step:LI&#13;
Specific Suggestions: SS&#13;
Intensive Therapy and referral:IT&#13;
Reflection and Review: The reflection and review of the elements added to the EX-PLISSIT model is one of the means of distinguishing this model with the PLISSIT model. In the EX-PLISSIT model, consideration and reflection of all interactions and interventions with the patient is necessary. By reflecting each intervention, the therapists will examine their actions and, by reviewing these interventions with patients, will be given the opportunity to give and receive more patients. The purpose of adding review and reflection to this model is to increase the therapist's self-awareness, so that the therapist and the client will select and implement the best treatment for the sex problem</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Sexual function. Timepoint: Before the intervention, two months and four months after the intervention. Method of measurement: questionnaire.</prim_outcome>
      <prim_outcome>Marital intimacy. Timepoint: Before the intervention, two months and four months after the intervention. Method of measurement: questionnaire.</prim_outcome>
      <prim_outcome>Sexual satisfaction. Timepoint: Before the intervention, two months and four months after the intervention. Method of measurement: questionnaire.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome></sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Vice chancellor of research and technology of shahroud university of medical science</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2017-06-20</approval_date>
        <contact_name>SHAHROUD University Of Medical  science Ethics Committee</contact_name>
        <contact_address>Shahroud University of Medical Sciences and Health Services, 7 Tir Square, Shahroud, Iran. Shahroud  Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
